Dagraduo

Dagraduo combines sitagliptin and dapagliflozin for oral use, offering a dual-action approach to managing certain health conditions. This medication is designed to support metabolic health and may be prescribed as part of a comprehensive treatment plan.

Dagraduo is primarily used to help manage blood sugar levels in adults with type 2 diabetes. It combines two active ingredients, sitagliptin and dapagliflozin, which work together to improve glycemic control. This medication is often used when diet and exercise alone are not sufficient to manage blood sugar levels effectively. It is important to consult a healthcare provider to determine if Dagraduo is suitable for your specific needs.

Common effects of Dagraduo may include improved blood sugar control and reduced HbA1c levels. Some individuals may experience side effects such as urinary tract infections, hypoglycemia, or gastrointestinal discomfort. It is essential to monitor your body's response to the medication and report any adverse effects to your healthcare provider.

Dagraduo should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Avoid using Dagraduo if you are allergic to sitagliptin, dapagliflozin, or any of the inactive ingredients. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Dagraduo may interact with certain medications, including insulin, other diabetes medications, and drugs that affect kidney function. It is important to discuss all your current medications with your healthcare provider before starting Dagraduo. Additionally, alcohol consumption should be moderated, as it can affect blood sugar levels and overall health.